Alternatives to FitFlow

A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.

Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.

Both prices came down since our last check: read live on 2026-08-26 the catalog reads from $79 a month for compounded semaglutide and from $159 for tirzepatide, against $99 and $169 in July. Same price at every dose is stated beside them, so titrating up does not raise the bill — but from is a floor and no ceiling or dose ladder is published anywhere. One question this record used to leave open is now answered on the site itself: yourEra says its clinician network is licensed in all 50 states, and repeats it in a badge and in its own founding story. The single price covers the telehealth visit, the medication, injection supplies, dose adjustments, unlimited messaging and shipping. Two things belong on your list before you pay. The refund policy stops refunds the moment the pharmacy begins preparing your order, whether or not it has shipped. And the Terms require you to have a device with a working video camera, which is the closest the site comes to telling you whether a live visit is part of this.

$99/mo semaglutide, $183/mo tirzepatide, all 50 states, a named physician personally reviewing every intake, and a real 5-7 day timeline — on a broader peptide platform where GLP-1 pricing is genuinely invisible unless you know to pull the page's own data bundle.

A flat $88/mo semaglutide and $157/mo tirzepatide with named medical groups and pharmacies behind it — the cheapest sticker in this batch, but a video visit is required and cancellation is by email, not a dashboard toggle.

Async-first compounded GLP-1 with a rarity for this list — free health coaching — at a flat one-price-all-doses rate. Fast and friendly up front; the strict, non-refundable fine print is the trade-off.

Pepti publishes the lowest semaglutide price in this entire roster — $99 a month, flat at every titration dose, with the medication, physician review, shipping, refill management and unlimited messaging with your prescribing doctor all inside it. Tirzepatide is $199 on the same all-in, flat-at-every-dose basis. That number is low enough to deserve skepticism, so it is worth saying exactly where it comes from: Pepti states it on a dedicated cost page, repeats it in its FAQ ('we keep pricing flat and transparent at $99/mo all-in'), and prices the comparison against Hims, Henry Meds and Mochi on the same page. It names two prescribing physicians and says its medication is compounded by FDA-registered 503A or 503B pharmacies, though it never names which. The real limits are reach and format: it ships to 36 states rather than 50, it is cash-pay only and bills no insurance, and its needle-free oral GLP-1/GIP drops cost $349 — well above its own injection.

A genuinely flat $99/month for either molecule, including consults and shipping per its own FAQ — undercut by a stale $139 figure still live in the page's meta description and a clinical-review team ('Lion MD') it shares with at least one other provider on this roster.

Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.